Latest Report Available at Orbis research Drug Discovery Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
Request sample copy of this report @ http://orbisresearch.com/contacts/request-sample/2081104 .
The global drug discovery market is expected to register a CAGR of approximately 8.0% during the forecast period, 2018 to 2023. North America dominates the market due to the favorable regulatory framework by the government and technological developments in that region.
Rise in Technology Advancements and Innovations
In recent past, the drug discovery has evolved significantly with emerging technologies helping in the process to become more refined, accurate and less time-consuming. High-throughput screening is one of the most widely used drug discovery technologies due to automation, multi-detector readers, imaging hardware and software. There are several other evolving technologies such as mass spectroscopy, protein and nucleic acid isolation, proteomics, RNAi, nanotechnology and others which contribute to advancement and innovations in drug discovery. The pharmaceutical and biotech companies are increasing their collaboration with contract development and manufacturing organizations which is also playing a crucial role in the development and innovations of new drugs.
Other factors contributing to the growth of this market are rising prevalence of the wide range of diseases such as cardiovascular and CNS related disorders, rising healthcare expenditure and the upcoming patent expiration of blockbuster drugs.
Huge Capital Investment with Low-Profit Margins
Every drug discovery and development requires a huge investment and involves a long time which often leads to lower profit margins for the companies by the time a drug is being marketed. The high cost is also related to high rate of drug candidate’s failure between initial drug discovery process to clinical trial phases which restricts the growth of this market. Apart from that, there is strict regulatory approval process across each region which follow rigid mechanism which impedes this market.
Browse Complete Report @ http://orbisresearch.com/reports/index/global-drug-discovery-market-segmented-by-drug-type-technology-service-end-user-and-geography-growth-trend-and-forecast-2018-2023 .
North America to Dominate this Market
The global drug discovery market is segmented by drug type, technology, service, end-user and geography. By geography, the market is segmented by North America, Europe, Asia-Pacific, Middle East and Africa and South America.
Geographically, North America is the most lucrative region for the growth of this market due to high number of top pharmaceutical and biotech companies business in this region. The favorable regulatory framework and encouraging regulatory policies for investors to research and develop new drugs help the growth of this market. Other factors such as high-income population and healthy returns on investments for new technologies are an integral part of the above factors. The Asia Pacific is expected to grow at a high rate due to rising disposable incomes, economic growth and increasing investment by pharmaceutical and biotechnology industry in this region.
Key Developments in the Market
January 2018: Merck launched Zinplava (bezlotoxumab) in UK prevention of recurrence of Clostridium difficile infection in adults at a high risk of for recurrence of CDI.
January 2018: BioCryst Pharmaceuticals Inc. and Idera Pharmaceuticals Inc planned for a definitive merger agreement to develop drugs for patients with rare diseases.
January 2018: AstraZeneca and Imperial College London collaborated to investigate biological drivers for respiratory disease such as asthma and chronic obstructive pulmonary disease.
Major key players: PFIZER inc, GLAXOSMITHKLINE llc, MERCK & CO inc, AGILENT TECHNOLOGIES inc, ELI LILLY AND COMPANY, F. HOFFMANN-LA ROCHE ltd, BAYER ag, ABBOTT LABORATORIES inc, ASTRAZENECA plc and SHIMADZU CORP
Reasons to Purchase This Report
Market analysis for the Global Drug Discovery Market, with region-specific assessments and competition analysis on a global and regional scale
Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
The treatment type that is expected to dominate the market
Regions that are expected to witness fastest growth during the forecast period
Identify the latest developments, market shares and strategies employed by the major market players
3 months analyst support along with the Market Estimate sheet in excel.
Customization of the Report
This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
Companies Mentioned:
- Pfizer inc,
- Glaxosmithkline llc,
- Merck & Co inc,
- Agilent Technologies inc,
- Eli Lilly and Company,
- Hoffmann-La Roche ltd,
- Bayer ag,
- Abbott Laboratories inc,
- Astrazeneca plc,
- Shimadzu corp
Some points From TOC:
- Introduction
1.1 Market Definition - Research Methodology
- Executive Summary
Purchase a copy of Drug Discovery Market visit @ http://orbisresearch.com/contact/purchase/2081104 For more information contact sales@orbisresearch.com
- Key Inferences
- Market Overview
5.1 Current Market Scenario
5.2 Porters Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Prevalence of Diverse Range Of Diseases
6.1.2 Rise in Technology Advancements and Innovations
6.1.3 Increase in Healthcare Expenditure
6.1.4 Patent Expiration of Blockbuster Drugs
6.2 Market Restraints
6.2.1 Huge Capital Investment with Low Profit Margins
6.2.2 Stringent Government Regulations
6.3 Opportunities
6.4 Challenges - Market Segmentation
7.1 By Drug Type
7.1.1 Small Molecule Drug
7.1.2 Biologics Drug
7.2 By Technology
7.2.1 High Throughput Screening
7.2.2 Biochips
7.2.3 Bioinformatics
7.2.4 Pharmacogenomics and Pharmacogenetics
7.2.5 Combinatorial Chemistry
7.2.6 Nanotechnology
7.2.7 Spectroscopy
7.2.8 Metabolomics
7.2.9 Others
7.3 By Service
7.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Services
7.3.2 Pharmaceutical Services
7.3.3 Chemical Services
7.3.4 Biological Services
7.4 By End-User
7.4.1 Research Institutes
7.4.2 Pharmaceutical Companies
7.4.3 Biotechnology Companies
7.4.4 Others
7.5 Segmentation by Geography
7.5.1 North America
7.5.1.1 United States
7.5.1.2 Canada
7.5.1.3 Mexico
7.5.2 Europe
7.5.2.1 France
7.5.2.2 Germany
7.5.2.3 United Kingdom
7.5.2.4 Italy
7.5.2.5 Spain
7.5.2.6 Rest of Europe
7.5.3 Asia-Pacific
7.5.3.1 China
7.5.3.2 Japan
7.5.3.3 India
7.5.3.4 Australia & New Zealand
7.5.3.5 South Korea
7.5.3.6 Rest of Asia-Pacific
7.5.4 Middle East and Africa
7.5.4.1 GCC
7.5.4.2 South Africa
7.5.4.3 Rest of Middle East and Africa
7.5.5 South America
7.5.5.1 Brazil
7.5.5.2 Argentina
7.5.5.3 Rest of South America
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment